Shen and collaborators recently showed using analysis of previously published GEO data sets (2 series of 54 AML younger than 15 year-old and 26 AML patients) that NCL mRNA expression levels is statistically higher in AML patients than in healthy donors [9–12]. The gene discussed is NUCLEOLIN; the disease is acute myeloid leukemia.